| My Account | Subscribe | Contact Us | Donate |
Rachel and her husband chose to adopt a baby instead of meeting the challenges of handling a high risk pregnancy and Rachel’s type 1 diabetes at the same time. She shares their thought process and ultimate happy ending about the decision to bring a child into their lives.
Hosting Hardball on MSNBC and The Chris Matthews Show keep Chris Matthews working long hours. But Matthews got a lesson in priorities and made some life changes when he was diagnosed with type 2.
Olivia and her dog both have diabetes and today they comfort and encourage each other through the rigors of dealing with the disease. Plus, find out what it means when your domestic pet is diagnosed with diabetes.
Smoking has severe effects on your diabetes and your health. Learn why diabetes and smoking are an especially bad combination and get some tips from the experts on how to quit.
CGM is a relatively new technology, but the information it provides is invaluable. Find out what CGM offers and whether it could help you.
The must-have resource for physicians, educators and medical professionals who focus on the treatment of diabetes.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
Latest Kids & Teens Articles
A multinational 10-year study, known as the Trial to Reduce Insulin-Dependent Diabetes in the Genetically at Risk (TRIGR), is enlisting the participation of newborns who have a parent or sibling with type 1 diabetes.
TRIGR is the first diabetes trial that will assess the relationship of infant formula consumption to the likelihood of developing type 1 diabetes in genetically susceptible infants. Its results could lead to early interventions, before babies develop antibodies that signal the beginning of an autoimmune attack that destroys the insulin-creating islet cells in the pancreas.
The study, which encourages and emphasizes breast-feeding, will compare several groups of breast-fed babies. When the babies are weaned, or if an infant needs supplementation, the diet of one group will be supplemented with a study formula called Nutramigen, a hydrolyzed cow's milk-based formula, in which the protein casein is broken down into smaller molecules, which are likely to be too small to stimulate the immune system. Another group of infants will supplement with Enfamil, a standard cow's milk-based formula (not hydrolyzed).
Researchers in Canada have shown that hydrolyzed cow's milk formula reduces the incidence of type 1 diabetes in diabetes-prone rats and mice by as much as 80 to 90 percent. They speculate that the absence of intact protein in the formula may be the reason.
If you are interested in having your baby participate in the TRIGR study, contact Peggy Franciscus, RN, at (412) 692-5250 or by e-mail at m_franciscus @yahoo.com, before or immediately after the baby's birth. For more information on the TRIGR study, log on to www.trigr.org.
The following U.S. sites are involved in the study:
St. Louis, Missouri
Seattle, Washington
New York, New York
Los Angeles, California
Pittsburgh, Pennsylvania
Puerto Rico
Categories: Kids & Teens, Support Groups, Type 1 Issues
Email to a Friend
Send a link to this page to your friends and colleagues.